Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events

Background FGF21 (fibroblast growth factor 21), a novel hepatokine regulating lipid metabolism, has been linked to atherosclerotic disease. However, whether this relationship exists in patients without nonalcoholic fatty liver disease is unclear. We assessed the association between serum FGF21 level...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Liang Wu, Lingling Qian, Lei Zhang, Jing Zhang, Jia Zhou, Yuehua Li, Xuhong Hou, Qichen Fang, Huating Li, Weiping Jia
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2020-06-01
Serie:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Soggetti:	atherosclerosis biomarker cardiovascular events fibroblast growth factor 21 nonalcoholic fatty liver disease
Accesso online:	https://www.ahajournals.org/doi/10.1161/JAHA.119.015226
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!